Abstract Background The Coronavirus disease-2019 (COVID-19) pandemic continues, and
the death toll continues to surge. This meta-analysis aimed to determine the efficacy of …

The objective of this study was to assess whether mesenchymal stem cells (MSCs) therapy
could offer survival advantages for patients with novel coronavirus disease 2019 (COVID …

Background The present study aims to better understand the efficacy and safety of
mesenchymal stromal cells (MSCs) in treating severe/critical patients with COVID-19 …

Background COVID-19 (coronavirus disease 2019) is a pandemic around the world, and its
treatment options often fail to achieve ideal results. There is a lot of controversy in the …

Abstract Background Coronavirus disease‐19 (COVID‐19) is a zoonotic disease that has
become a global pandemic. The fast evolution of the COVID‐19 pandemic and persist …

Introduction To date, no specific antivirus drugs or vaccines have been available to prevent
or treat the COVID-19 pandemic. Mesenchymal stem cell (MSC) therapy may be a promising …

Background Mesenchymal stem/stromal cells (MSCs) and their secreted products are a
promising therapy for COVID-19 given their immunomodulatory and tissue repair …

BACKGROUND Currently, ongoing trials of mesenchymal stem cells (MSC) therapies for
coronavirus disease 2019 (COVID-19) have been reported. AIM In this study, we …

Background: Coronavirus disease 2019 (COVID-19) is an infectious respiratory disease
prevalent worldwide with a high mortality rate, and there is currently no specific medicine to …

Background The coronavirus disease 2019 (COVID-19) has become a serious public health
issue. In COVID-19 patients, the elevated levels of inflammatory cytokines lead to the …